Author

Lucia Mokaba

OpenAlex ID: A5115793743

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

2025 · Simon E Koele, Krista Stoycheva, et al. · Journal of Antimicrobial Chemotherapy · 5

Works count: 2

Citation count: 35

H-index: 2

I10-index: 1